Tanaka, Kiyo http://orcid.org/0000-0001-6812-6150
Masuda, Norikazu
Hayashi, Naoki
Sagara, Yasuaki
Hara, Fumikata
Kadoya, Takayuki
Matsui, Akira
Miyazaki, Chieko
Shien, Tadahiko
Tokunaga, Eriko
Hayashi, Takako
Niikura, Naoki
Maeda, Shigeto
Komoike, Yoshihumi
Bando, Hiroko
Kanbayashi, Chizuko
Iwata, Hiroji
Funding for this research was provided by:
the National Cancer Center Research and Development Fund (26-A-4)
the Japan Agency for Medical Research and Development (20ck0106429h0003)
Article History
Received: 22 September 2020
Accepted: 7 February 2021
First Online: 18 February 2021
Compliance with ethical standards
:
: Dr. Norikazu Masuda reports grants, personal fees and other from Chugai and Eisai, personal fees and other from AstraZeneca, Pfizer, Elli-Lilly, Takeda, Kyowa-Kirin, Novartis, and Daiichi-Sankyo, other from MSD. Dr. Naoki Hayashi reports personal fees from Chugai, Novartis, AstraZeneca Kyowa-Kirin, Genomic Health inc, Allergan, Devixcor Japan, and Pfizer. Dr. Naoki Niikura reports grants and personal fees from Chugai, personal fees from AstraZeneca, Pfizer, Novartis and Eisai, grants from Nippon Mediphysics, Daiichi-Sankyo, BMS, and MSD. Dr. Hiroko Bando reports personal fees from AstraZeneca, Eisai, Kyowa-Kirin, Taiho, Chugai, Nihon Kayaku, Pfizer, and Novartis. Dr. Hiroji Iwata reports grants and personal fees from Novartis, AstraZeneca, Pfizer, Elli-Lilly, Daiichi-Sankyo, Kyowa-Kirin, and Chugai, grants from MSD and Byer, personal fees from Eisai. The others have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
: Informed consent was obtained from all individual participants included in the study by opt-out.